Flow cytometry revealed a significant reduction in the percentage of CD45+ cancer cells in the peripheral blood of the mice received PKMYT1‐knockdown K562 cells, compared with that in the peripheral blood of the mice of wild‐type group (Figure 7g). Here, PKMYT1 is linked to cancer.